GLUCAXER

Serial Number 87636346
606

Registration Progress

Application Filed
Oct 6, 2017
Under Examination
May 8, 2018
Approved for Publication
Mar 13, 2018
Published for Opposition
Mar 13, 2018
Registered

Trademark Image

GLUCAXER

Basic Information

Serial Number
87636346
Filing Date
October 6, 2017
Published for Opposition
March 13, 2018
Abandonment Date
December 9, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 9, 2019
Classes
005 010

Rights Holder

Xeris Pharmaceuticals, Inc.

03
Address
180 N LaSalle Street, Suite 1810
Chicago, IL 60601

Ownership History

Xeris Pharmaceuticals, Inc.

Original Applicant
03
Austin, TX

Xeris Pharmaceuticals, Inc.

Owner at Publication
03
Chicago, IL

Legal Representation

Attorney
Alicia Morris Groos

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

28 events
Date Code Type Description Documents
Jun 23, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
May 19, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Dec 9, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 9, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 10, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 8, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 8, 2019 EXT2 S SOU EXTENSION 2 FILED Loading...
May 8, 2019 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 2, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 31, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 31, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 31, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 27, 2018 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 27, 2018 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 8, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 13, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 13, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 21, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 6, 2018 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jan 29, 2018 ALIE A ASSIGNED TO LIE Loading...
Jan 18, 2018 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 18, 2018 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jan 18, 2018 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 18, 2018 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 18, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 12, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 13, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 10, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device pre-filled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Medical apparatus, namely, an injection device for administering drugs
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 010